跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Glaxosmithkline S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 13, 2025
Approval ID
66d361637aa574c2
Company
Glaxosmithkline S.A.
Type
Standard
Approval Details
Approval Id
66d361637aa574c2
Drug Cima Aemps Name
FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Register Number
90137
Holder Company Name
Glaxosmithkline S.A.
Marketing Company Name
Glaxosmithkline S.A.
Holder Company Detail Path
/organization/glaxosmithkline-sa
Marketing Company Detail Path
/organization/glaxosmithkline-sa
Authorization Date
2025-02-13
Dosage Form
SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
0,5 ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Glaxosmithkline S.A.
Company Detail Path
/organization/glaxosmithkline-sa
Company Information
Pharmaceutical Company Name
GLAXOSMITHKLINE SA
Country Name
Spain
City Name
tres cantos,madrid,country_es
Address
CALLE DE SEVERO OCHOA (- PQ TECNOLOGICO DE MADRID) 2
Active Ingredients
VIRUS INFLUENZA GRIPE A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVADO
15 Microgramo(s) Hemaglutinina
VIRUS INFLUENZA GRIPE A/THAILAND/8/2022 (H3N2) IVR-237 CEPA SIMILAR A (A/THAILAND/8/2022)
15 Microgramo(s) Hemaglutinina
VIRUS INFLUENZA GRIPE CEPA SIMILAR A B/AUSTRIA/1359417/2021-(B/AUSTRIA/1359417/2021, BVR-26)
15 Microgramo(s) Hemaglutinina
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 13, 2025
Approval ID
66d361637aa574c2
Type
Standard
Back to CIMA-AEMPS Approvals
